6.
Wu F, Zhang J, Wang Q, Liu W, Zhang X, Ning F
. Identification of immune-associated genes in vascular dementia by integrated bioinformatics and inflammatory infiltrates. Heliyon. 2024; 10(4):e26304.
PMC: 10879030.
DOI: 10.1016/j.heliyon.2024.e26304.
View
7.
Baskys A, Cheng J
. Pharmacological prevention and treatment of vascular dementia: approaches and perspectives. Exp Gerontol. 2012; 47(11):887-91.
DOI: 10.1016/j.exger.2012.07.002.
View
8.
Togo T, Akiyama H, Iseki E, Kondo H, Ikeda K, Kato M
. Occurrence of T cells in the brain of Alzheimer's disease and other neurological diseases. J Neuroimmunol. 2002; 124(1-2):83-92.
DOI: 10.1016/s0165-5728(01)00496-9.
View
9.
Kwak Y, Yang Y, Koo M
. Anxiety in Dementia. Dement Neurocogn Disord. 2019; 16(2):33-39.
PMC: 6427954.
DOI: 10.12779/dnd.2017.16.2.33.
View
10.
Huang Q, Voloudakis G, Ren Y, Yoon Y, Zhang E, Kajiwara Y
. Presenilin1/γ-secretase protects neurons from glucose deprivation-induced death by regulating miR-212 and PEA15. FASEB J. 2017; 32(1):243-253.
PMC: 5731132.
DOI: 10.1096/fj.201700447RR.
View
11.
Tian Y, Zhang Y, Wang Y, Chen Y, Fan W, Zhou J
. Hydrogen, a Novel Therapeutic Molecule, Regulates Oxidative Stress, Inflammation, and Apoptosis. Front Physiol. 2022; 12:789507.
PMC: 8721893.
DOI: 10.3389/fphys.2021.789507.
View
12.
Gorelick P, Scuteri A, Black S, DeCarli C, Greenberg S, Iadecola C
. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke. 2011; 42(9):2672-713.
PMC: 3778669.
DOI: 10.1161/STR.0b013e3182299496.
View
13.
Han J, Park H, Maharana C, Gwon A, Park J, Baek S
. Alzheimer's disease-causing presenilin-1 mutations have deleterious effects on mitochondrial function. Theranostics. 2021; 11(18):8855-8873.
PMC: 8419044.
DOI: 10.7150/thno.59776.
View
14.
Kuraoka M, Furuta T, Matsuwaki T, Omatsu T, Ishii Y, Kyuwa S
. Direct experimental occlusion of the distal middle cerebral artery induces high reproducibility of brain ischemia in mice. Exp Anim. 2009; 58(1):19-29.
DOI: 10.1538/expanim.58.19.
View
15.
Pemberton J, Pogmore J, Andrews D
. Neuronal cell life, death, and axonal degeneration as regulated by the BCL-2 family proteins. Cell Death Differ. 2020; 28(1):108-122.
PMC: 7852532.
DOI: 10.1038/s41418-020-00654-2.
View
16.
Caroni P, Becker M
. The downregulation of growth-associated proteins in motoneurons at the onset of synapse elimination is controlled by muscle activity and IGF1. J Neurosci. 1992; 12(10):3849-61.
PMC: 6575961.
View
17.
Jorm A, Jolley D
. The incidence of dementia: a meta-analysis. Neurology. 1998; 51(3):728-33.
DOI: 10.1212/wnl.51.3.728.
View
18.
Roman G, Tatemichi T, Erkinjuntti T, Cummings J, Masdeu J, Garcia J
. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993; 43(2):250-60.
DOI: 10.1212/wnl.43.2.250.
View
19.
Tao G, Song G, Qin S
. Molecular hydrogen: current knowledge on mechanism in alleviating free radical damage and diseases. Acta Biochim Biophys Sin (Shanghai). 2019; 51(12):1189-1197.
DOI: 10.1093/abbs/gmz121.
View
20.
. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health. 2022; 7(2):e105-e125.
PMC: 8810394.
DOI: 10.1016/S2468-2667(21)00249-8.
View